Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
FOLD

Amicus

$10.26

-0.18 (-1.72%)

, INSM

Insmed

$16.80

-0.47 (-2.72%)

13:03
07/11/17
07/11
13:03
07/11/17
13:03
Hot Stocks
Small cap rare disease biotechs jump after peer Amicus gets FDA nod »

Shares of small cap…

FOLD

Amicus

$10.26

-0.18 (-1.72%)

INSM

Insmed

$16.80

-0.47 (-2.72%)

XLRN

Acceleron

$32.60

-0.07 (-0.21%)

CRBP

Corbus Pharmaceuticals

$6.45

0.05 (0.78%)

PTCT

PTC Therapeutics

$18.82

-0.47 (-2.44%)

AGIO

Agios Pharmaceuticals

$54.50

-0.41 (-0.75%)

IDRA

Idera Pharmaceuticals

$1.77

-0.03 (-1.67%)

DMTX

Dimension Therapeutics

$1.25

-0.05 (-3.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

  • 28

    Sep

  • 24

    Oct

CELG

Celgene

$131.93

-0.63 (-0.48%)

, XLRN

Acceleron

$32.60

-0.07 (-0.21%)

16:28
07/10/17
07/10
16:28
07/10/17
16:28
Hot Stocks
Celgene potentially worth $200 per share, says analyst »

Shares of biotech giant…

CELG

Celgene

$131.93

-0.63 (-0.48%)

XLRN

Acceleron

$32.60

-0.07 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 30

    Aug

  • 11

    Sep

XLRN

Acceleron

$34.10

0.15 (0.44%)

05:49
06/26/17
06/26
05:49
06/26/17
05:49
Recommendations
Acceleron analyst commentary at Piper Jaffray »

Acceleron price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARQL

ArQule

$1.17

0.03 (2.63%)

, NLNK

NewLink Genetics

$7.36

-0.04 (-0.54%)

04:55
06/25/17
06/25
04:55
06/25/17
04:55
Conference/Events
European Hematology Association to hold a conference »

22nd Congress of the EHA…

ARQL

ArQule

$1.17

0.03 (2.63%)

NLNK

NewLink Genetics

$7.36

-0.04 (-0.54%)

BLUE

bluebird bio

$112.00

-6.5 (-5.49%)

XLRN

Acceleron

$34.10

0.15 (0.44%)

BLCM

Bellicum Pharmaceuticals

$13.39

-0.59 (-4.22%)

CRSP

CRISPR Therapeutics

$16.44

0.3 (1.86%)

AGIO

Agios Pharmaceuticals

$59.18

1.76 (3.07%)

CELG

Celgene

$134.31

0.63 (0.47%)

STML

Stemline

$9.10

0.6 (7.06%)

CTIX

Cellceutix

KPTI

Karyopharm

$9.97

0.01 (0.10%)

RARX

RA Pharmaceuticals

$23.01

0.01 (0.04%)

CDTX

Cidara Therapeutics

$6.70

-0.2 (-2.90%)

GBT

Global Blood Therapeutics

$29.85

0.6 (2.05%)

PTLA

Portola Pharmaceuticals

$56.06

17.81 (46.56%)

TGTX

TG Therapeutics

$11.95

-0.05 (-0.42%)

VSTM

Verastem

$2.32

-0.06 (-2.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 29

    Jun

  • 29

    Jun

  • 06

    Jul

  • 11

    Jul

  • 26

    Sep

ARQL

ArQule

$1.17

0.03 (2.63%)

, NLNK

NewLink Genetics

$7.36

-0.04 (-0.54%)

04:55
06/24/17
06/24
04:55
06/24/17
04:55
Conference/Events
European Hematology Association to hold a conference »

22nd Congress of the EHA…

ARQL

ArQule

$1.17

0.03 (2.63%)

NLNK

NewLink Genetics

$7.36

-0.04 (-0.54%)

BLUE

bluebird bio

$112.00

-6.5 (-5.49%)

XLRN

Acceleron

$34.10

0.15 (0.44%)

BLCM

Bellicum Pharmaceuticals

$13.39

-0.59 (-4.22%)

CRSP

CRISPR Therapeutics

$16.44

0.3 (1.86%)

AGIO

Agios Pharmaceuticals

$59.18

1.76 (3.07%)

CELG

Celgene

$134.31

0.63 (0.47%)

STML

Stemline

$9.10

0.6 (7.06%)

CTIX

Cellceutix

KPTI

Karyopharm

$9.97

0.01 (0.10%)

RARX

RA Pharmaceuticals

$23.01

0.01 (0.04%)

CDTX

Cidara Therapeutics

$6.70

-0.2 (-2.90%)

GBT

Global Blood Therapeutics

$29.85

0.6 (2.05%)

PTLA

Portola Pharmaceuticals

$56.06

17.81 (46.56%)

TGTX

TG Therapeutics

$11.95

-0.05 (-0.42%)

VSTM

Verastem

$2.32

-0.06 (-2.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 27

    Jun

  • 29

    Jun

  • 29

    Jun

  • 06

    Jul

  • 11

    Jul

  • 26

    Sep

Over a month ago
XLRN

Acceleron

$33.95

1.52 (4.69%)

, CELG

Celgene

$133.68

0.85 (0.64%)

05:40
06/23/17
06/23
05:40
06/23/17
05:40
Hot Stocks
Acceleron says results from ongoing trials demonstrate increases in hemoglobin »

Acceleron Pharma (XLRN)…

XLRN

Acceleron

$33.95

1.52 (4.69%)

CELG

Celgene

$133.68

0.85 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

ARQL

ArQule

$1.14

-0.01 (-0.87%)

, NLNK

NewLink Genetics

$7.40

0.04 (0.54%)

04:55
06/23/17
06/23
04:55
06/23/17
04:55
Conference/Events
European Hematology Association to hold a conference »

22nd Congress of the EHA…

ARQL

ArQule

$1.14

-0.01 (-0.87%)

NLNK

NewLink Genetics

$7.40

0.04 (0.54%)

BLUE

bluebird bio

$118.50

-1.8 (-1.50%)

XLRN

Acceleron

$33.95

1.52 (4.69%)

BLCM

Bellicum Pharmaceuticals

$13.98

1.33 (10.51%)

CRSP

CRISPR Therapeutics

$16.14

1.1 (7.31%)

AGIO

Agios Pharmaceuticals

$57.42

0.64 (1.13%)

CELG

Celgene

$133.68

0.85 (0.64%)

STML

Stemline

$8.50

0.15 (1.80%)

CTIX

Cellceutix

KPTI

Karyopharm

$9.96

0.46 (4.84%)

RARX

RA Pharmaceuticals

$23.00

0.42 (1.86%)

CDTX

Cidara Therapeutics

$6.90

-0.35 (-4.83%)

GBT

Global Blood Therapeutics

$29.25

-1.5 (-4.88%)

PTLA

Portola Pharmaceuticals

$38.25

-1.24 (-3.14%)

TGTX

TG Therapeutics

$12.00

0.55 (4.80%)

VSTM

Verastem

$2.38

0.08 (3.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 24

    Jun

  • 27

    Jun

  • 29

    Jun

  • 06

    Jul

  • 11

    Jul

  • 26

    Sep

ARQL

ArQule

$1.15

0.01 (0.88%)

, NLNK

NewLink Genetics

$7.36

0.61 (9.04%)

08:26
06/22/17
06/22
08:26
06/22/17
08:26
Conference/Events
European Hematology Association to hold a conference »

22nd Congress of the EHA…

ARQL

ArQule

$1.15

0.01 (0.88%)

NLNK

NewLink Genetics

$7.36

0.61 (9.04%)

BLUE

bluebird bio

$120.30

7.3 (6.46%)

XLRN

Acceleron

$32.43

1.1 (3.51%)

BLCM

Bellicum Pharmaceuticals

$12.65

-0.23 (-1.79%)

CRSP

CRISPR Therapeutics

$15.04

0.16 (1.08%)

AGIO

Agios Pharmaceuticals

$56.78

4.03 (7.64%)

CELG

Celgene

$132.83

6.61 (5.24%)

STML

Stemline

$8.35

0.05 (0.60%)

CTIX

Cellceutix

KPTI

Karyopharm

$9.50

0.18 (1.93%)

RARX

RA Pharmaceuticals

$22.58

0.21 (0.94%)

CDTX

Cidara Therapeutics

$7.25

0.3 (4.32%)

GBT

Global Blood Therapeutics

$30.75

2.3 (8.08%)

PTLA

Portola Pharmaceuticals

$39.49

0.49 (1.26%)

TGTX

TG Therapeutics

$11.45

0.35 (3.15%)

VSTM

Verastem

$2.30

0.12 (5.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 22

    Jun

  • 22

    Jun

  • 24

    Jun

  • 27

    Jun

  • 29

    Jun

  • 06

    Jul

  • 11

    Jul

XLRN

Acceleron

$32.43

1.1 (3.51%)

04:55
06/22/17
06/22
04:55
06/22/17
04:55
Conference/Events
Acceleron management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 22

    Jun

XLRN

Acceleron

$31.33

1.02 (3.37%)

12:07
06/21/17
06/21
12:07
06/21/17
12:07
Conference/Events
Acceleron management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 22

    Jun

  • 22

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.